Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma.

Trial Profile

Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma.

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Busulfan (Primary) ; Fludarabine (Primary)
  • Indications Neuroblastoma
  • Focus Adverse reactions
  • Acronyms RICE-NK
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 18 Jan 2011 Planned initiation date changed from 1 Sep 2010 to 1 Sep 2011 according to ClinicalTrials.gov.
    • 14 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top